Delivery Order SPE2DX22D0010-SPE2D826FBQ22
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $32,142.24 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on September 23, 2025, with an ultimate completion date of September 24, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to supply pharmaceutical products and medical supplies to support federal military and healthcare operations. The work will be performed at AmerisourceBergen's Corporate Office location in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $137,671.25 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 5, 2025, with completion scheduled for December 8, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply provision. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor and sole...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,502.62 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 1, 2025, with completion expected by December 2, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. The order is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $14,865.12 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on November 6, 2025, with an ultimate completion date of November 7, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply fulfillment. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $16,670.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 4, 2025, with completion scheduled for December 5, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. AmerisourceBergen, a major pharmaceutical distributor...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $12,157.17 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 1, 2025, with completion scheduled for December 2, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply fulfillment. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $41,482.50 delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 8, 2025, with completion expected by December 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,469.56 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 5, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply fulfillment. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a $108,637.53 delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 6, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply fulfillment. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $15,637.33 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply products to support federal healthcare needs. The work will be performed at AmerisourceBergen's corporate...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FBQ22Delivery Order
The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $46,339.59 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 9, 2025, with completion scheduled for December 10, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare operations. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative plans multiple regional awards across different contractors, positioning AmerisourceBergen as one of the primary vendors supporting federal medical procurement requirements across diverse therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $46.3k | 12/8/25 |